Sunday, July 16, 2017 9:33:25 PM
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 0.859 Volume: 193,980
$ Intraday High: 0.867 % Change: 3.482
$ Change: 0.029 $ Volume: 166,609
$ Open: 0.867
$ Previous Close: 0.830
3 Month: $ High / Low 2.250 / 0.710 Volume 3m avg: 291,534
Promoter: Penny Stock Prophet
Compensation: None Listed or Image Compensation
Date: 7/14/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 0.859 Volume: 193,980
$ Intraday High: 0.867 % Change: 3.482
$ Change: 0.029 $ Volume: 166,609
$ Open: 0.867
$ Previous Close: 0.830
3 Month: $ High / Low 2.250 / 0.710 Volume 3m avg: 291,534
Promoter: OTC Tip Reporter
Compensation: To date we have been compensated One Hundred Thousand dollars USD to profile ITUS. Please be advised THAT we have been compensated an additional Thirty-Five Thousand dollars USD by a non-affiliated THIRD party for marketing exposure on ITUS beginning on July 12th, 2017 ending on July 14th, 2017.
Date: 7/14/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 0.830 Volume: 968,974
$ Intraday High: 0.950 % Change: 7.806
$ Change: 0.060 $ Volume: 804,248
$ Open: 0.872
$ Previous Close: 0.770
3 Month: $ High / Low 2.250 / 0.710 Volume 3m avg: 288,693
Promoter: OTC Tip Reporter
Compensation: To date we have been compensated One Hundred Thousand dollars USD to profile ITUS. Please be advised THAT we have been compensated an additional Thirty-Five Thousand dollars USD by a non-affiliated third party for marketing exposure on ITUS beginning on July 12th, 2017 ending on July 14th, 2017.
Date: 7/13/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 0.830 Volume: 968,974
$ Intraday High: 0.950 % Change: 7.806
$ Change: 0.060 $ Volume: 804,248
$ Open: 0.872
$ Previous Close: 0.770
3 Month: $ High / Low 2.250 / 0.710 Volume 3m avg: 288,693
Promoter: The Penny Stock Hero
Compensation: Hero Team We have been compensated 2K by Cream Consulting LLC for distribution of this email on ITUS TSPS, Somwar Peth, Pune, MH 85207, INDIA Unsubscribe | Change Subscriber Options
Date: 7/13/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 0.830 Volume: 968,974
$ Intraday High: 0.950 % Change: 7.806
$ Change: 0.060 $ Volume: 804,248
$ Open: 0.872
$ Previous Close: 0.770
3 Month: $ High / Low 2.250 / 0.710 Volume 3m avg: 288,693
Promoter: Penny Stock Prophet
Compensation: None Listed or Image Compensation
Date: 7/13/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 1.170 Volume: 685,670
$ Intraday High: 1.320 % Change: 1.739
$ Change: 0.020 $ Volume: 802,234
$ Open: 1.270
$ Previous Close: 1.150
3 Month: $ High / Low 3.050 / 0.710 Volume 3m avg: 249,490
Promoter: The Penny Stock Hero
Compensation: Hero Team Please make sure to read and understand our complete disclaimer below (image file) We have been compensated 2K by Cream Consulting LLC for distribution of this email on ITUS TSPS, Somwar Peth, Pune, MH 85207, INDIA Unsubscribe | Change Subscriber Options
Date: 7/3/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 1.170 Volume: 685,670
$ Intraday High: 1.320 % Change: 1.739
$ Change: 0.020 $ Volume: 802,234
$ Open: 1.270
$ Previous Close: 1.150
3 Month: $ High / Low 3.050 / 0.710 Volume 3m avg: 249,490
Promoter: OTC Tip Reporter
Compensation: To date we have been compensated Sixty Five Thousand dollars USD to profile ITUS. Please be advised THAT we have been compensated an additional Thirty Five Thousand dollars USD by a non-affiliated third party FOR marketing exposure.
Date: 7/3/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 1.170 Volume: 685,670
$ Intraday High: 1.320 % Change: 1.739
$ Change: 0.020 $ Volume: 802,234
$ Open: 1.270
$ Previous Close: 1.150
3 Month: $ High / Low 3.050 / 0.710 Volume 3m avg: 249,490
Promoter: Penny Stock Prophet
Compensation: None Listed or Image Compensation
Date: 7/3/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 1.150 Volume: 1,630,514
$ Intraday High: 1.200 % Change: 19.779
$ Change: 0.190 $ Volume: 1,875,091
$ Open: 0.990
$ Previous Close: 0.960
3 Month: $ High / Low 3.700 / 0.710 Volume 3m avg: 194,375
Promoter: Penny Stock Prophet
Compensation: None Listed or Image Compensation
Date: 6/28/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 1.150 Volume: 1,630,514
$ Intraday High: 1.200 % Change: 19.779
$ Change: 0.190 $ Volume: 1,875,091
$ Open: 0.990
$ Previous Close: 0.960
3 Month: $ High / Low 3.700 / 0.710 Volume 3m avg: 194,375
Promoter: OTC Tip Reporter
Compensation: Please be advised we have been compensated for investor relations and media services for ITUS in THE amount of Thirty Thousand dollars USD by, a non-affiliated third party for marketing exposure which has since expired.
Date: 6/28/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 1.040 Volume: 1,632,779
$ Intraday High: 1.140 % Change: 40.541
$ Change: 0.300 $ Volume: 1,698,090
$ Open: 0.900
$ Previous Close: 0.740
3 Month: $ High / Low 3.700 / 0.710 Volume 3m avg: 165,079
Promoter: OTC Tip Reporter
Compensation: Please be advised we have been compensated for inve.stor relations and media services for ITUS in THE amount of Thirty Thousand dollars USD by, a non-affiliated third party for marketing exposure.
Date: 6/26/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 1.040 Volume: 1,632,779
$ Intraday High: 1.140 % Change: 40.541
$ Change: 0.300 $ Volume: 1,698,090
$ Open: 0.900
$ Previous Close: 0.740
3 Month: $ High / Low 3.700 / 0.710 Volume 3m avg: 165,079
Promoter: The Penny Stock Hero
Compensation: Trade Green, The Hero Team Please make sure to read and understand our disclaimer below (image file) We have been compensated 2K by Cream Consulting LLC for distribution of this email on ITUS TSPS, Somwar Peth, Pune, MH 85207, INDIA Unsubscribe | Change Subscriber Options
Date: 6/26/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Company: ITUS Corporation ( ITUS )
End of Day: $ Close: 1.040 Volume: 1,632,779
$ Intraday High: 1.140 % Change: 40.541
$ Change: 0.300 $ Volume: 1,698,090
$ Open: 0.900
$ Previous Close: 0.740
3 Month: $ High / Low 3.700 / 0.710 Volume 3m avg: 165,079
Promoter: Penny Stock Prophet
Compensation: Please be advised we have been compensated for inv.estor relations and media services for ITUS in THE amount of Thirty Thousand dollars USD by, a non-affiliated third party for marketing exposure.
Date: 6/26/2017 View:View MessageShare:Post to Facebook
Share to Twitter
Recent ANIX News
- Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine • PR Newswire (US) • 09/24/2024 12:30:00 PM
- Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer Conference • PR Newswire (US) • 09/18/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/06/2024 09:00:27 PM
- Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium • PR Newswire (US) • 09/03/2024 12:30:00 PM
- Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference • PR Newswire (US) • 08/26/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 04:42:57 PM
- Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting • PR Newswire (US) • 07/29/2024 12:45:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/29/2024 10:05:44 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 05:26:12 PM
- Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy • PR Newswire (US) • 07/23/2024 12:15:00 PM
- Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology • PR Newswire (US) • 07/17/2024 12:00:00 PM
- Anixa Biosciences Announces $5 Million Share Repurchase Program • PR Newswire (US) • 07/15/2024 12:30:00 PM
- Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial • PR Newswire (US) • 06/24/2024 12:45:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 01:22:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 01:56:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 03:18:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 02:03:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 04:24:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 02:57:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/04/2024 09:00:57 PM
- Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial • PR Newswire (US) • 05/21/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 12:35:37 PM
- Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines • PR Newswire (US) • 05/08/2024 12:25:00 PM
- Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja • PR Newswire (US) • 05/06/2024 12:05:00 PM
- Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024 • PR Newswire (US) • 04/30/2024 11:45:00 AM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM